Mixed Glioma — Trials

Mixed Glioma — Trials · CancerIndex

Clinical trials

Registered studies

101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05600491	A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme	unknown	Phase 3	78	Sun Yat-sen UniversityOTHER	1	Oct 31, 2022	clinicaltrials
NCT02209428	A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas	unknown	Phase 2	54	Huashan HospitalOTHER	1	Feb 21, 2019	clinicaltrials
NCT01765088	A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas	unknown	Phase 3	300	Sun Yat-sen UniversityOTHER	1	Feb 23, 2018	clinicaltrials
NCT02629757	A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas

Data updated 22 days agoSource updated Oct 31, 2022source: clinicaltrials